Composition: Ivermectin BP 3 mg; Ivermectin IP 6 mg (uncoated)
Usage: Treatment of selected parasitic infections as prescribed
Category: Antiparasitic / Anthelmintic
Therapeutic category: Antiparasitic agent
SKU: Ivermectin Tablets
Categories: Pharmaceutical Exporter India, Pharmaceutical Formulations India, WHO GMP Certified Formulations
Ivermectin Tablets is listed in our pharmaceutical product portfolio for business-to-business enquiries. Product-specific formulation details, available strengths, dosage form, pack configuration and supply terms should be confirmed against the current product specification before ordering.
For distributor, wholesaler, hospital procurement and export enquiries, please request the applicable product specifications, batch documentation, shelf-life information, packaging options and regulatory documents. Availability and documentation depend on the product and destination market.
Healthy Life Pharma Pvt. Ltd. presents Ivermectin Tablets for antiparasitic treatment. Ivermectin is an anthelmintic medicine used for certain infections caused by parasitic worms. Use for other parasitic conditions, including scabies or public-health programs, depends on local approvals and clinical guidance.
Manufacturer: Healthy Life Pharma Pvt. Ltd. Exporter: Healthy Inc. Contract manufacturing and export arrangements are subject to confirmation of product approvals, available capacity and destination-country requirements.
| Product name | Ivermectin Tablets |
|---|---|
| Composition – BP | Each tablet contains Ivermectin BP 3 mg |
| Composition – IP | Each uncoated tablet contains Ivermectin IP 6 mg |
| Strengths confirmed by supplied labels | 3 mg and 6 mg |
| Other strength | 12 mg mentioned in marketing description; availability and approved composition not confirmed |
| CAS number | 70288-86-7 |
| Therapeutic class | Anthelmintic / antiparasitic (not an antibiotic) |
| Dosage form | Oral tablets; 6 mg specified as uncoated |
| Packaging / shelf life | Confirm against approved product label and stability data |
| SKU | Ivermectin Tablets |
Ivermectin has limited water solubility, making particle properties, blend uniformity, tablet disintegration and dissolution important formulation considerations. Suitable manufacturing methods may include controlled blending, granulation and compression, depending on the validated product formula. Specific claims about micronization, solid dispersions or dispersible pediatric versions require product-level confirmation.
Relevant quality controls may include identity, assay, related substances, content uniformity, dissolution and stability testing against the applicable approved pharmacopoeial or registered specification. Ivermectin contains closely related homologues; applicable composition requirements should be verified for the selected standard. Batch certificates and manufacturing authorizations should be confirmed before commercial publication.
Ivermectin acts primarily on glutamate-gated chloride channels in susceptible invertebrates, disrupting neuromuscular function and leading to paralysis of parasites. Clinical indications depend on the product's local authorization and treatment guidelines.
Ivermectin is not an antibacterial antibiotic and is not an approved treatment for viral infections such as COVID-19.
For prospective B2B partners, documentation may include a certificate of analysis, product specifications, stability data and registration dossiers where available. FSC, COPP, GMP documents and CTD/ACTD submissions must be verified for the actual manufacturing site, product and destination country. Shipment terms and packaging options are quotation-dependent.
Q: What strengths are listed?
A: Ivermectin BP 3 mg and Ivermectin IP 6 mg are specified in the supplied product labels. A 12 mg variant is mentioned separately but not substantiated by a composition statement.
Q: Is ivermectin an antibiotic?
A: No. It is an antiparasitic/anthelmintic medicine.
Q: Is it taken as a single dose?
A: Treatment schedules vary by infection, body weight, local guidance and patient circumstances; some conditions require repeat treatment.
Q: Is it suitable for every patient?
A: No. Pregnancy, young children, interacting medicines and certain co-infections require individualized clinical assessment.
Use only according to the prescribing clinician and the approved local label. Oral ivermectin dosing is typically weight-based and varies by condition. Strongyloidiasis, onchocerciasis and scabies use different protocols and retreatment intervals. Administration with or without food must follow the particular product label and indication; do not assume a universal regimen. Never substitute veterinary ivermectin formulations for human medicines.
Store in the original packaging, protected from moisture and light as stated on the approved product label. The supplied description suggests storage below 30°C, but the final storage conditions must match the registered product. Keep out of reach of children.